Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.745 USD | +1.91% | -2.09% | -32.56% |
Business Summary
Number of employees: 267
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Collaborative Arrangements
100.0
%
| 411 | 100.0 % | 443 | 100.0 % | +7.83% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 411 | 100.0 % | 443 | 100.0 % | +7.83% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 66 | 08-12-31 |
Sravan Emany
DFI | Director of Finance/CFO | 46 | 21-12-05 |
Marcel Moulaison
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Chief Tech/Sci/R&D Officer | 65 | 19-01-27 | |
Greg Martini
IRC | Investor Relations Contact | - | 17-05-31 |
Susanna H. Huh
PRN | Corporate Officer/Principal | - | 22-08-31 |
Mike Nanfito
SAM | Sales & Marketing | - | 12-04-30 |
John Minardo
LAW | General Counsel | 49 | 21-08-02 |
Ronald Silver
AUD | Comptroller/Controller/Auditor | 42 | 18-05-31 |
Andrew Davis
PRN | Corporate Officer/Principal | 38 | 21-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alexander Denner
BRD | Director/Board Member | 54 | 20-11-08 |
Jay Shepard
BRD | Director/Board Member | 66 | 20-12-02 |
Mark Currie
BRD | Director/Board Member | 69 | 19-12-31 |
Andrew Dreyfus
BRD | Director/Board Member | 65 | 16-03-31 |
Thomas McCourt
CEO | Chief Executive Officer | 66 | 08-12-31 |
Director/Board Member | 64 | 19-03-31 | |
Julie McHugh
CHM | Chairman | 59 | 14-01-31 |
Jon Duane
BRD | Director/Board Member | 65 | 19-03-31 |
Marla Kessler
BRD | Director/Board Member | 54 | 19-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 156,528,648 | 153,278,890 ( 97.92 %) | 0 | 97.92 % |
Company contact information
Ironwood Pharmaceuticals, Inc.
100 Summer Street Suite 2300
02110, Boston
+617 621 7722
http://www.ironwoodpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.26% | 1.19B | |
-1.45% | 41.35B | |
+41.76% | 40.38B | |
+3.23% | 39.05B | |
-12.11% | 26.67B | |
+2.04% | 24.07B | |
-23.56% | 18.36B | |
-3.13% | 11.68B | |
+20.91% | 11.6B | |
+7.55% | 11.15B |
- Stock Market
- Equities
- IRWD Stock
- Company Ironwood Pharmaceuticals, Inc.